327
Views
10
CrossRef citations to date
0
Altmetric
Review

Animal models of osteogenesis imperfecta: applications in clinical research

, , &
Pages 41-55 | Published online: 27 Sep 2016

References

  • BaljetBAspects of the history of osteogenesis imperfecta (Vrolik’s syndrome)Ann Anat200218411711876477
  • SillenceDOSennADanksDMGenetic heterogeneity in osteogenesis imperfectaJ Med Genet1979162101116458828
  • Kamoun-GoldratASLe MerrerMFAnimal models of osteogenesis imperfecta and related syndromesJ Bone Miner Metab200725421121817593490
  • RauchFGlorieuxFHOsteogenesis imperfectaLancet200436394181377138515110498
  • BodianDLChanTFPoonAMutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationshipsHum Mol Genet200918346347118996919
  • JaenischRHarbersKSchniekeAGermline integration of Moloney murine leukemia virus at the Mov13 locus leads to recessive lethal mutation and early embryonic deathCell19833212092166825169
  • HarbersKKuehnMDeliusHJaenischRInsertion of retrovirus into the first intron of α1(I) collagen gene to embryonic lethal mutation in miceProc Natl Acad Sci U S A1984815150415086324198
  • BarkerDDWuHHartungSBreindlMJaenischRRetrovirus-induced insertional mutagenesis: mechanism of collagen mutation in Mov13 miceMol Cell Biol19911110515451631922037
  • SmithROsteogenesis imperfecta: from phenotype to genotype and back againInt J Exp Pathol19947542332417947227
  • Iruela-ArispeMLVernonRBWuHJaenischRSageEHType I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast functionDev Dyn199620721711838906420
  • GlorieuxFHSponsellerPDShapiroJRByersPHOsteogenesis Imperfecta: A Translational Approach to Brittle Bone DiseaseLondonAcademic Press2014
  • ChipmanSDSweetHOMcBrideDJDefective proα2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfectaProc Natl Acad Sci U S A1993905170117058446583
  • BonadioJSaundersTLTsaiETransgenic mouse model of the mild dominant form of osteogenesis imperfectaProc Natl Acad Sci U S A19908718714571492402497
  • JepsenKJSchafflerMBKuhnJLGouletRWBonadioJGoldsteinSAType I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissueJ Biomech19973011–12114111479456382
  • KuznetsovaNVForlinoACabralWAMariniJCLeikinSStructure, stability and interactions of type I collagen with GLY349-CYS substitution in α1(I) chain in a murine osteogenesis imperfecta modelMatrix Biol200423210111215246109
  • KozloffKMCardenABergwitzCBrittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strengthJ Bone Miner Res200419461462215005849
  • CarrieroAZimmermannEAPalusznyAHow tough is brittle bone? Investigating osteogenesis imperfecta in mouse boneJ Bone Miner Res20142961392140124420672
  • FratzlPParisOKlaushoferKLandisWBone mineralization in an osteogenesis imperfecta mouse model studied by small-angle X-ray scatteringJ Clin Invest19969723964028567960
  • NiyibiziCLiFPotential implications of cell therapy for osteogenesis imperfectaInt J Clin Rheumtol200941576620490372
  • CarrieroADoubeMVogtMAltered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragilityBone20146111612424373921
  • McBrideDJrShapiroJDunnMBone geometry and strength measurements in aging mice with the oim mutationCalcif Tissue Int19986221721769437052
  • CamachoNPHouLToledanoTRThe material basis for reduced mechanical properties in oim mice bonesJ Bone Miner Res19991422642729933481
  • ColeWGThe Nicholas Andry Award – 1996: the molecular pathology of osteogenesis imperfectaClin Orthop Relat Res1997343235248
  • ColeWGAdvances in osteogenesis imperfectaClin Orthop Relat Res2002401616
  • BoydeATraversRGlorieuxFJonesSThe mineralization density of iliac crest bone from children with osteogenesis imperfectaCalcif Tissue Int199964318519010024373
  • NymanJSReyesMWangXEffect of ultrastructural changes on the toughness of boneMicron200536756658216169742
  • SabanJZussmanMHaveyRPatwardhanASchneiderGKingDHeterozygous oim mice exhibit a mild form of osteogenesis imperfectaBone19961965755798968022
  • MisofKLandisWKlaushoferKFratzlPCollagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stressJ Clin Invest19971001409202055
  • DaleyEStreetenEASorkinJDVariable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse modelJ Bone Miner Res201025224726119594296
  • StaceyABatemanJChoiTMascaraTColeWJaenischRPerinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen geneNature198833261601311362450280
  • BatemanJFMascaraTColeWGStaceyAJaenischRThe study of collagen structure and function by site-directed mutagenesis of collagen genesAnn N Y Acad Sci199058013243292337302
  • Gailus-DurnerVFuchsHBeckerLIntroducing the German Mouse Clinic: open access platform for standardized phenotypingNat Methods20052640340415908916
  • LisseTSThieleFFuchsHER stress-mediated apoptosis in a new mouse model of osteogenesis imperfectaPLoS Genet200842e718248096
  • ForlinoAPorterFDLeeEJWestphalHMariniJCUse of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an α1(I) G349C substitution variability in phenotype in BrtlIV miceJ Biol Chem199927453379233793110608859
  • UvegesTECollin-OsdobyPCabralWACellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursorsJ Bone Miner Res200823121983199418684089
  • BoskeyALVerdelisKSpevakLMineral and matrix changes in Brtl/+ teeth provide insights into mineralization mechanismsBiomed Res Int2013201329581223802117
  • ForlinoACabralWABarnesAMMariniJCNew perspectives on osteogenesis imperfectaNat Rev Endocrinol20117954055721670757
  • SokolovBPMaysPKKhillanJSProckopDJTissue- and development-specific expression in transgenic mice of a type I procollagen (COL1A1) minigene construct with 2.3 kB of the promoter region and 2 kB of the 3′-flanking region: specificity is independent of the putative regulatory sequences in the first intronBiochemistry19933235924292498369292
  • KhillanJSOlsenAKontusaariSSokolovBProckopDTransgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfectaJ Biol Chem19912663423373233791744131
  • PereiraRKhillanJSHelminenHJHumeELProckopDJTransgenic mice expressing a partially deleted gene for type I procollagen (COL1A1): a breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineralJ Clin Invest19939127097168432871
  • KhillanJSLiSWProckopDJPartial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen geneProc Natl Acad Sci U S A19949114629863028022775
  • CampbellBWoottonJKrookLDeMarcoJMinorRClinical signs and diagnosis of osteogenesis imperfecta in three dogsJ Am Vet Med Assoc199721121831879227748
  • CampbellBGWoottonJAMacLeodJNMinorRRSequence of normal canine COL1A1 cDNA and identification of a heterozygous α1(I) collagen Gly208AIa mutation in a severe case of canine osteogenesis imperfectaArch Biochem Biophys20003841374611147834
  • CampbellBGWoottonJAMacleodJNMinorRRCanine COL1A2 mutation resulting in C-terminal truncation of pro-α2(I) and severe osteogenesis imperfectaJ Bone Miner Res20011661147115311393792
  • DeakSBVan Der RestMProckopDJAltered helical structure of a homotrimer of α1(I) chains synthesized by fibroblasts from a variant of osteogenesis imperfectaColl Relat Res1985543053134053561
  • CampbellBGWoottonJAMacLeodJNMinorRRSequence of canine COL1A2 cDNA: nucleotide substitutions affecting the cyanogen bromide peptide map of the α2(I) chainArch Biochem Biophys1998357167759721184
  • Van EedenFGranatoMSchachUGenetic analysis of fin formation in the zebrafish, Danio rerioDevelopment199612312552629007245
  • AsharaniPKeuppKSemlerOAttenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafishAm J Hum Genet201290466167422482805
  • DuránIMarí-BeffaMSantamaríaJBecerraJSantos-RuizLActinotrichia collagens and their role in fin formationDev Biol2011354116017221420398
  • FisherSJagadeeswaranPHalpernMERadiographic analysis of zebrafish skeletal defectsDev Biol20032641647614623232
  • CabralWAChangWBarnesAMProlyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfectaNat Genet200739335936517277775
  • ShapiroJRLietmanCGroverMPhenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutationJ Bone Miner Res20132871523153023408678
  • LietmanCDMaromRMunivezEA transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutationJ Bone Miner Res201530348949825251575
  • HomanEPRauchFGrafeIMutations in SERPINF1 cause osteogenesis imperfecta type VIJ Bone Miner Res201126122798280321826736
  • BarnesAMChangWMorelloRDeficiency of cartilage-associated protein in recessive lethal osteogenesis imperfectaN Engl J Med2006355262757276417192541
  • MariniJCCabralWABarnesAMNull mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfectaCell Tissue Res20103391597019862557
  • DollJAStellmachVMBouckNPPigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreasNat Med20039677478012740569
  • BoganRRiddleRCLiZA mouse model for human osteogenesis imperfecta type VIJ Bone Miner Res20132871531153623413146
  • MorelloRBertinTKChenYCRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfectaCell2006127229130417055431
  • Fratzl-ZelmanNMorelloRLeeBCRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VIIBone201046382082619895918
  • BaldridgeDLenningtonJWeisMGeneralized connective tissue disease in Crtap−/− mousePloS One201055e1056020485499
  • VrankaJAPokidyshevaEHayashiLProlyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bonesJ Biol Chem201028522172531726220363744
  • PokidyshevaETufaSBreseeCBrigandeJVBächingerHPProlyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone jointsMatrix Biol2013321394423186870
  • van DijkFSNesbittIMZwikstraEHPPIB mutations cause severe osteogenesis imperfectaAm J Hum Genet200985452152719781681
  • BarnesAMCarterEMCabralWALack of cyclophilin B in osteogenesis imperfecta with normal collagen foldingN Engl J Med2010362652152820089953
  • BarnesAMCabralWAWeisMAbsence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrixHum Mutat201233111589159822718341
  • PyottSMSchwarzeUChristiansenHEMutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypesHum Mol Genet20112081595160921282188
  • ChristiansenHESchwarzeUPyottSMHomozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfectaAm J Hum Genet201086338939820188343
  • NagataKHSP47 as a collagen-specific molecular chaperone: function and expression in normal mouse developmentSemin Cell Dev Biol200314527528214986857
  • IshidaYKubotaHYamamotoAKitamuraABächingerHPNagataKType I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesisMol Biol Cell20061752346235516525016
  • ChoiJWSutorSLLindquistLSevere osteogenesis imperfecta in cyclophilin B-deficient micePLoS Genet2009512e100075019997487
  • IshikawaYWirzJVrankaJANagataKBächingerHPBiochemical characterization of the prolyl 3-hydroxylase 1 cartilage-associated protein cyclophilin B complexJ Biol Chem200928426176411764719419969
  • NagaiNHosokawaMItoharaSEmbryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesisJ Cell Biol200015061499150610995453
  • TasabMBattenMRBulleidNJHsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagenEMBO J200019102204221110811611
  • SeeligerFLeebTPetersMBrügmannMFehrMHewicker-TrautweinMOsteogenesis imperfecta in two litters of dachshundsVet Pathol200340553053912949410
  • DrögemüllerCBeckerDBrunnerAA missense mutation in the SERPINH1 gene in dachshunds with osteogenesis imperfectaPLoS Genet200957e100057919629171
  • AlanayYKrakowDResponse to Shaheen et alAm J Hum Genet2010872308
  • ShaheenRAl-OwainMSakatiNAlzayedZSAlkurayaFSFKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?Am J Hum Genet201087230630720696291
  • AlanayYAvayganHCamachoNMutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfectaAm J Hum Genet201086455155920362275
  • LapunzinaPAglanMTemtamySIdentification of a frameshift mutation in osterix in a patient with recessive osteogenesis imperfectaAm J Hum Genet201087111011420579626
  • Martínez-GlezVValenciaMCaparrós-MartínJAIdentification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfectaHum Mutat201233234335022052668
  • ShaheenRAlazamiAMAlshammariMJStudy of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutationJ Med Genet2012491063063523054245
  • KeuppKBeleggiaFKayseriliHMutations in WNT1 cause different forms of bone fragilityAm J Hum Genet201392456557423499309
  • PyottSMTranTTLeistritzDFWNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfectaAm J Hum Genet201392459059723499310
  • FahiminiyaSMajewskiJMortJMoffattPGlorieuxFHRauchFMutations in WNT1 are a cause of osteogenesis imperfectaJ Med Genet201350534534823434763
  • LaineCMJoengKSCampeauPMWNT1 mutations in early-onset osteoporosis and osteogenesis imperfectaN Engl J Med2013368191809181623656646
  • SymoensSMalfaitFD’hondtSDeficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humansOrphanet J Rare Dis2013815424079343
  • Mendoza-LondonoRFahiminiyaSMajewskiJRecessive osteogenesis imperfecta caused by missense mutations in SPARCAm J Hum Genet201596697998526027498
  • LietmanCDRajagopalAHomanEPConnective tissue alterations in Fkbp10−/− miceHum Mol Genet201423184822483124777781
  • NakashimaKZhouXKunkelGThe novel zinc finger- containing transcription factor osterix is required for osteoblast differentiation and bone formationCell20021081172911792318
  • BaekWYLeeMAJungJWPositive regulation of adult bone formation by osteoblast-specific transcription factor osterixJ Bone Miner Res20092461055106519113927
  • FisherSHalpernMEPatterning the zebrafish axial skeleton requires early chordin functionNat Genet199923444244610581032
  • LanePWSwayingMouse News Lett1967361
  • ThomasKRCapecchiMRTargeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar developmentNature199034662878478502202907
  • ThomasKRMusciTSNeumannPECapecchiMRSwaying is a mutant allele of the proto-oncogene Wnt-1Cell19916759699761835670
  • JoengKSLeeYCJiangMMThe swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutationsHum Mol Genet201423154035404224634143
  • BargmanRPoshamRBoskeyADiCarloERaggioCPleshkoNComparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfectaOsteoporos Int20122331141115021901481
  • EvansKSheppardLRaoSMartinROberbauerAPamidronate alters the growth plate in the oim mouse model for osteogenesis imperfectaInt J Biomed Sci20095434535223675157
  • UvegesTEKozloffKMTyJMAlendronate treatment of the Brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formationJ Bone Miner Res200924584985919113917
  • McCarthyEARaggioCLHossackMDAlendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse modelPediatr Res200252566067012409511
  • RaoSEvansKOberbauerAMartinRBisphosphonate treatment in the oim mouse model alters bone modeling during growthJ Biomech200841163371337619022450
  • CamachoNCarrollPRaggioCFourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim miceCalcif Tissue Int200372560460912574874
  • EvansKLauSOberbauerAMartinRAlendronate affects long bone length and growth plate morphology in the oim mouse model for osteogenesis imperfectaBone200332326827412667554
  • MisofBMRoschgerPBaldiniTDifferential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouseBone200536115015815664013
  • QuenzerJBoachie-AdjeiKBoskeyALProckopDCamachoNPRaggioCLUse of alendronate in long-term treatment of transgenic OI micePoster presented at: 50th Annual Meeting of the Orthopaedic Research SocietyMarch 7–10, 2004San Francisco, CA
  • BoskeyALMarinoJSpevakLAre changes in composition in response to treatment of a mouse model of osteogenesis imperfecta sex-dependent?Clin Orthop Relat Res201547382587159825903941
  • MeganckJBegunDMcElderryJFracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaBone201356120421223774443
  • WangHDBoyceAMTsaiJYEffects of denosumab treatment and discontinuation on human growth platesJ Clin Endocrinol Metab201499389189724423331
  • SemlerONetzerCHoyer-KuhnHBeckerJEyselPSchoenauEFirst use of the RANKL antibody denosumab in osteogenesis imperfecta type VIJ Musculoskelet Neuronal Interact201212318318822947550
  • DelosDYangXRicciardiBFMyersERBostromMPCamachoNPThe effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfectaJ Orthop Res200826215316417729310
  • BargmanRHuangABoskeyALRaggioCPleshkoNRANKL inhibition improves bone properties in a mouse model of osteogenesis imperfectaConnect Tissue Res201051212313120053133
  • KostenuikPJOsteoprotegerin and RANKL regulate bone resorption, density, geometry and strengthCurr Opin Pharmacol20055661862516188502
  • KostenuikPJNguyenHQMcCabeJDenosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKLJ Bone Miner Res200924218219519016581
  • AnastasilakisADToulisKAPolyzosSAAnastasilakisCDMakrasPLong-term treatment of osteoporosis: safety and efficacy appraisal of denosumabTher Clin Risk Manag2012829530622767993
  • NeerRMArnaudCDZanchettaJREffect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med2001344191434144111346808
  • JiangYZhaoJLiaoEYDaiRCWuXPGenantHKApplication of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studiesJ Bone Miner Metab200523112213115984427
  • DempsterDWCosmanFKurlandESEffects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy studyJ Bone Miner Res200116101846185311585349
  • KurlandESCosmanFMcMahonDJRosenCJLindsayRBilezikianJPParathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markersJ Clin Endocrinol Metab20008593069307610999788
  • RodanGAMartinTJTherapeutic approaches to bone diseasesScience200028954841508151410968781
  • BlackDMGreenspanSLEnsrudKEThe effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosisN Engl J Med2003349131207121514500804
  • MognettiBMarinoSBarberisAExperimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fractureCalcif Tissue Int201189216317121701938
  • KabackLASoungDYNaikATeriparatide (1-34 human PTH) regulation of osterix during fracture repairJ Cell Biochem2008105121922618494002
  • DhillonRSSchwarzEMTeriparatide therapy as an adjuvant for tissue engineering and integration of biomaterialsJ Mater Res2011461117113121857768
  • JacobsonJAYanoso-SchollLReynoldsDGTeriparatide therapy and beta-tricalcium phosphate enhance scaffold reconstruction of mouse femoral defectsTissue Eng Part A2010173–438939820807012
  • ReynoldsDGTakahataMLernerALO’KeefeRJSchwarzEMAwadHATeriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine modelBone201148356257020950720
  • OrwollESShapiroJVeithSEvaluation of teriparatide treatment in adults with osteogenesis imperfectaJ Clin Invest2014124249149824463451
  • SinderBPEddyMMOminskyMSCairdMSMariniJCKozl-offKMSclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfectaJ Bone Miner Res2013281738022836659
  • HorwitzEMAndreefMFrassoniFMesenchymal stromal cellsCurr Opin Hematol200613641942517053453
  • LiFWangXNiyibiziCDistribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantationStem Cells200725123183319317823236
  • GuillotPVAbassOBassettJDIntrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta miceBlood200811131717172517967940
  • CampagnoliCRobertsIAKumarSBennettPRBellantuonoIFiskNMIdentification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrowBlood20019882396240211588036
  • VanleeneMSaldanhaZCloydKLTransplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue propertiesBlood201111731053106021088133
  • PereiraRFO’HaraMDLaptevAVMarrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfectaProc Natl Acad Sci U S A1998953114211479448299
  • LiFWangXNiyibiziCBone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfectaBone201047354655520570757
  • PanaroniCGioiaRLupiAIn utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfectaBlood2009114245946819414862
  • NiyibiziCWangSMiZRobbinsPGene therapy approaches for osteogenesis imperfectaGene Ther200411440841614724682
  • SchniekeADziadekMBatemanJIntroduction of the human pro-α1(I) collagen gene into pro-α1(I)-deficient Mov-13 mouse cells leads to formation of functional mouse-human hybrid type I collagenProc Natl Acad Sci U S A19878437647683468512
  • Millington-WardSMcMahonHPFarrarGJEmerging therapeutic approaches for osteogenesis imperfectaTrends Mol Med200511629930515949772
  • WeissBDavidkovaGZhouLWAntisense RNA gene therapy for studying and modulating biological processesCell Mol Life Sci199955333435810228554
  • ForlinoAMariniJCOsteogenesis imperfecta: prospects for molecular therapeuticsMol Genet Metab200071122523211001814
  • EvansCGene delivery to boneAdv Drug Deliv Rev201264121331134022480730
  • RoseLUludağHRealizing the potential of gene-based molecular therapies in bone repairJ Bone Miner Res201328112245226223553878
  • OsawaKOkuboYNakaoKKoyamaNBesshoKOsteoinduction by repeat plasmid injection of human bone morphogenetic protein-2J Gene Med2010121293794421069645
  • VanleeneMShefelbineSJTherapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse boneBone201353250751423352925
  • XieLRubinCJudexSEnhancement of the adolescent murine musculoskeletal system using low-level mechanical vibrationsJ Appl Physiol (1985)200810441056106218258802
  • MalachanneEDureisseixDJourdanFNumerical model of bone remodeling sensitive to loading frequency through a poroelastic behavior and internal fluid movementsJ Mech Behav Biomed Mater20114684985721616466
  • LauneyMEBuehlerMJRitchieROOn the mechanistic origins of toughness in boneAnnu Rev Mater Res2010402553